Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

MUMBAI, India, 8 luglio 2026 /PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), azienda leader a livello mondiale nel settore farmaceutico, della salute…